Nosyfit Nasal Spray
By Nosyfit
10ml Nasal Solution in a Bottle

Composition
Xylometazoline(0.1% w/v)

Manufacturer - Johnson & Smith Co
B-48, III Stage, Peenya Industrial Estate, Peenya, Bengaluru-560058, Karnataka, India

Expires on or after
July, 2026

liver
Safety Advice - Liver No interactions have been found or established with the use of Nosyfit Nasal Spray that could potentially affect the liver. It is important to remember that every individual may react differently to medications, so if you have any concerns about the impact of Nosyfit Nasal Spray on your liver, it is recommended to consult with your healthcare provider for personalized guidance.

kidney
No interaction or effects on the kidneys have been found or established with Nosyfit Nasal Spray.

alcohol
No interaction has been found or established between alcohol and Nosyfit Nasal Spray. It is always advisable to consult your doctor regarding alcohol consumption when using Nosyfit Nasal Spray, especially during pregnancy.

driving
There is no known interaction or caution related to driving when using Nosyfit Nasal Spray. It is considered safe for driving.

pregnancy
Nosyfit Nasal Spray may not be safe during pregnancy, as animal studies indicate potential harm to the baby. Consult your doctor for a thorough evaluation of benefits and risks before using this product.

breastfeeding
Nosyfit Nasal Spray is likely safe for breastfeeding as per limited human data, indicating no significant risk to the baby.
| Habit Forming | No |
| Chemical Class | Phenylpropane Derivative |
| Therapeutic Class | - |
| Action Class | Sympthatomimmetics- alpha 1 (Nasal) |
₹52
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024
